Jitendra – Page 22 – Scilex Holding

06 Jan

SEC FIlings

Certification

November 17, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Registration of securities

November 17, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

06 Jan

SEC FIlings

Initial statement of beneficial ownership of securities

December 14, 2022
Posted by Jitendra

05 Jan

SEC FIlings

Correspondence

November 17, 2022
Posted by Jitendra

05 Jan

SEC FIlings

Correspondence

November 17, 2022
Posted by Jitendra

28 Dec

SEC FIlings

Correspondence

November 17, 2022
Posted by Jitendra

28 Dec

SEC FIlings

Registration of securities – amendment

November 17, 2022
Posted by Jitendra

Posts by Jitendra

Certification

Registration of securities

Initial statement of beneficial ownership of securities

Initial statement of beneficial ownership of securities

Initial statement of beneficial ownership of securities

Initial statement of beneficial ownership of securities

Correspondence

Correspondence

Correspondence

Registration of securities – amendment

Gloperba Launch – Nasdaq-2024

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Gout Awareness Day – May 22

Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch